Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 5-6, 2010, Pages 590-602

  van den Broek, Irene ^a   Sparidans, Rolf W ^a   Schellens, Jan H M ^a,b   Beijnen, Jos H ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Biomarkers; Bradykinins; Breast cancer; C4a 1337 1350 ; Fibrinogen 605 629 ; ITIH4 666 687 ; LC MS MS; quantification

Indexed keywords

ANALYTES; BOVINE PLASMA; BREAST CANCER; CATION EXCHANGES; ELECTROSPRAY SOURCE; HEAVY CHAIN; HUMAN SERUM; INTER-ASSAY PRECISION; INTERNAL STANDARDS; LC-MS/MS; LIQUID CHROMATOGRAPHY COUPLED TO TANDEM MASS SPECTROMETRY; MATRIX; MERCAPTOETHANOL; MIXED MODE; MULTIPLE REACTION MONITORING; QUANTITATIVE ASSAY; RAPID DEGRADATION; SERUM SAMPLES; SOLID-PHASE EXTRACTION; TRIPLE-QUADRUPOLE MASS SPECTROMETER; TRYPSIN INHIBITOR;

BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; EXTRACTION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; PEPTIDES; PHOTODEGRADATION; POSITIVE IONS;

BIOMARKERS;

BRADYKININ; BRADYKININ DERIVATIVE; BRADYKININ[1-8]; BRADYKININ[3 HYDROXYPROLINE]; CAPTOPRIL; COMPLEMENT COMPONENT 4A; COMPLEMENT COMPONENT C4; FIBRINOGEN; INTER ALPHA TRYPSIN INHIBITOR; ISOLEUCINE; MERCAPTOETHANOL 3 GUANIDINOETHYLTHIOPROPANOIC ACID; PROPIONIC ACID DERIVATIVE; TUMOR MARKER; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; DEGRADATION; HEAVY CHAIN; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ALPHA-GLOBULINS; ANIMALS; BRADYKININ; BREAST NEOPLASMS; CATTLE; CHROMATOGRAPHY, LIQUID; COMPLEMENT C4A; FEMALE; FIBRINOGEN; HUMANS; LINEAR MODELS; PLASMA; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

BOVINAE;

EID: 75549085660     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.01.011     Document Type: Article

References (21)

1. Koomen J.M., Li D., Xiao L.C., Liu T.C., Coombes K.R., Abbruzzese J., and Kobayashi R. J. Proteome Res. 4 (2005) 972
2. Villanueva J., Shaffer D.R., Philip J., Chaparro C.A., Erdjument-Bromage H., Olshen A.B., Fleisher M., Lilja H., Brogi E., Boyd J., Sanchez-Carbayo M., Holland E.C., Cordon-Cardo C., Scher H.I., and Tempst P. J. Clin. Invest. 116 (2006) 271
3. Diamandis E.P. J. Natl. Cancer Inst. 96 (2004) 353
4. Diamandis E.P. Mol. Cell Proteomics 3 (2004) 367
5. Villanueva J., Philip J., Chaparro C.A., Li Y., Toledo-Crow R., DeNoyer L., Fleisher M., Robbins R.J., and Tempst P. J. Proteome Res. 4 (2005) 1060
6. Engwegen J.Y.M.N., Alberts M., Knol J.C., Jimenez C.R., Depla A.C.T.M., Tuynman H., van Heukelem H.A., Snel P., Smits M.E., Cats A., Schellens J.H.M., and Beijnen J.H. Proteomics Clin. Appl. 2 (2008) 936
7. Timms J.F., Arslan-Low E., Gentry-Maharaj A., Luo Z., T'Jampens D., Podust V.N., Ford J., Fung E.T., Gammerman A., Jacobs I., and Menon U. Clin. Chem. 53 (2007) 645
8. Yi J., Kim C., and Gelfand C.A. J. Proteome Res. 6 (2007) 1768
9. http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_009224 (C4a), NP_002209 (ITIH4), NP_000499 (Fibrinogen-α), June 2009.
10. Song J., Patel M., Rosenzweig C.N., Chan-Li Y., Sokoll L.J., Fung E.T., Choi-Miura N.H., Goggins M., Chan D.W., and Zhang Z. Clin. Chem. 52 (2006) 1045
11. Fung E.T., Yip T.T., Lomas L., Wang Z., Yip C., Meng X.Y., Lin S., Zhang F., Zhang Z., Chan D.W., and Weinberger S.R. Int. J. Cancer 115 (2005) 783
12. Cheng A.J., Chen L.C., Chien K.Y., Chen Y.J., Chang J.T., Wang H.M., Liao C.T., and Chen I.H. Clin. Chem. 51 (2005) 2236
13. Shi Q., Harris L.N., Lu X., Li X., Hwang J., Gentleman R., Iglehart J.D., and Miron A. J. Proteome Res. 5 (2006) 2947
14. van den Broek I., Sparidans R.W., Schellens J.H., and Beijnen J.H. Rapid Commun. Mass Spectrom. 22 (2008) 2915
15. Wilson S.R., Boix F., Holm A., Molander P., Lundanes E., and Greibrokk T. J. Sep. Sci. 28 (2005) 1751
16. Pellacani A., Brunner H.R., and Nussberger J. J. Cardiovasc. Pharmacol. 20 Suppl. 9 (1992) S28
17. Murphey L.J., Hachey D.L., Vaughan D.E., Brown N.J., and Morrow J.D. Anal. Biochem. 292 (2001) 87
18. http://www.fda.gov/cder/guidance/4252fnl.htm, Guidance for industry Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CEDR), Center for Veterinary Medicine (CVM), BP, May 2001.
19. Bischoff R., and Kolbe H.V. J. Chromatogr. B Biomed. Appl. 662 (1994) 261
20. Marshall P., Heudi O., McKeown S., Amour A., and Abou-Shakra F. Rapid Commun. Mass Spectrom. 16 (2002) 220
21. National Centre for Biotechnology Information (NCBI), http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=XP_584742.3 (C4a, bos taurus), NP_001015590 (ITIH4, bos taurus), NP_001028798 (Fibrinogen-α, bos taurus), 229123 (Bradykinin, Bos taurus), June 2009.